Javascript must be enabled to continue!
John Philpot
View through CrossRef
The process and history of Master John Philpot, examined, condemned, and martyred for the maintenance and defence of the gospel’s cause, against the Antichristian See of Rome.
Next followeth the constant martyrdom of Master John Philpot. … He was of a worshipful house, a knight’s...
Title: John Philpot
Description:
The process and history of Master John Philpot, examined, condemned, and martyred for the maintenance and defence of the gospel’s cause, against the Antichristian See of Rome.
Next followeth the constant martyrdom of Master John Philpot.
… He was of a worshipful house, a knight’s.
Related Results
John Philpot – Archdeacon of Winchester and Martyr (1515–1555)
John Philpot – Archdeacon of Winchester and Martyr (1515–1555)
This is the most comprehensive account yet of the life of John Philpot, archdeacon of Winchester cathedral and martyr, burned at the stake in 1555. Included is an outline of his tr...
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within ...
John Philpot Curran (1750 - 1817)
John Philpot Curran (1750 - 1817)
Portrait of the lawyer and politician John Philpot Curran...
Prediction of disability-free survival in healthy older people
Prediction of disability-free survival in healthy older people
AbstractProlonging survival in good health is a fundamental societal goal. However, the leading determinants of disability-free survival in healthy older people have not been well ...
OTEC Project Area Survey
OTEC Project Area Survey
ABSTRACT
The Preliminary Design Phase Field Survey of the Oahu OTEC project consisted of precision bathymetric surveying, sub-bottom profiling bottom imaging with...
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
OBJECTIVE
In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of...
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Abstract
The ODYSSEY OUTCOMES trial, comprising over 47 000 patient-years of placebo-controlled observation, demonstrated important reductions in the risk of recurre...
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Background:
Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on...

